Experts On… Delivering Value to Biopharma Sponsors

Having a multidisciplinary team gives us deep & diverse expertise to tap across our discovery endeavors. This series shares those insights with you.

Small molecule biomarkers provide the next layer of biological insight to help complete the picture of human health and disease that genetics and proteomics have formed to date.

Sapient’s Dr. Tanya Nguyen, Head of Scientific Operations, shares context of use examples for these biomarkers and the applications in which sponsors are seeing the greatest value and impact on their pipelines.

Because small molecule biomarkers are highly conserved across species, they are typically highly translatable, increasing the likelihood of finding a biomarker in early discovery research that can be applied in later clinical trials. This is an important feature of biomarkers for biopharma to advance drug development efforts and make findings actionable for clinical implementation.

Want to hear more from our Experts On additional discovery topics? Click here to see more videos.